Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MOTS-C Injection: Technique Comparison

Subcutaneous (subq) 29G–31G 4–6mm into fat layer Abdomen, anterior thigh, dorsal upper arm Moderate. Peaks 30–90 min Standard route for MOTS-C; consistent bioavailability, minimal discomfort, easy self-administration Intramuscular (IM) 23G–25G 1–1.5 inches int

This comparison does not assign a generated winner or score.

  • Subcutaneous (subq)
  • 29G–31G
  • 4–6mm into fat layer
  • Abdomen, anterior thigh, dorsal upper arm
  • Moderate. Peaks 30–90 min
  • Standard route for MOTS-C; consistent bioavailability, minimal discomfort, easy self-administration
  • Intramuscular (IM)
  • 23G–25G
  • 1–1.5 inches into muscle
  • Vastus lateralis, gluteus, deltoid
  • Faster. Peaks 15–45 min
  • Not typically used for MOTS-C; no documented bioavailability advantage and higher injection site pain
  • Intravenous (IV)
  • 20G–22G
  • Direct venous access
  • Antecubital fossa, hand veins
  • Immediate. Systemic within seconds
  • Requires clinical setting; bypasses first-pass metabolism but offers no therapeutic benefit for MOTS-C's mechanism
More references

Related material